Data / Form D filings / BIOXYTRAN, INC
BIOXYTRAN, INC: Form D filings
BIOXYTRAN, INC, a biotechnology company in Needham, MA, filed 6 Form D notices with the SEC between 2018 and 2023. The latest, on March 13, 2023, reports $130,000 sold of a $6 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- C/O BIOXYTRAN, INC., 75 2ND AVE, SUITE 605 STE 605, Needham, MA, 02494
- Phone
- (617) 494-1199
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Year incorporated
- 2018
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1445815
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 13, 2023 | New notice | $6,000,000 | $130,000 | $5,870,000 | 3 | Nov 28, 2022 | sec.gov |
| Aug 16, 2022 | New notice | $600,000 | $600,000 | 1 | Aug 16, 2022 | sec.gov | |
| Jan 13, 2022 | New notice | $1,500,000 | $1,467,000 | $33,000 | 34 | Jan 5, 2022 | sec.gov |
| Jul 20, 2021 | New notice | $3,266,845 | $3,266,845 | 9 | May 2, 2021 | sec.gov | |
| Nov 5, 2019 | New notice | $1,000,000 | $332,300 | $667,700 | 1 | Oct 23, 2019 | sec.gov |
| Nov 6, 2018 | New notice | $500,000 | $250,000 | $250,000 | 1 | Oct 25, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ola Soderquist | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Mar 13, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BIOXYTRAN, INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.